The pharmaceutical contract packaging market is projected to grow at a CAGR of 8.89% from 2026 to 2031, with North America holding the largest market share.
HYDERABAD, TELANGANA, INDIA, August 4, 2026 /EINPresswire.com/ — According to Mordor Intelligence, the pharmaceutical contract packaging market is projected to grow from USD 20.82 billion in 2026 to USD 31.88 billion by 2031, registering a CAGR of 8.89% during the forecast period. Market growth is driven by increasing outsourcing of pharmaceutical packaging operations, rising demand for biologics and specialty medicines, expanding adoption of serialization technologies, sustainable packaging solutions, and integrated CDMO services. Investments in AI-enabled packaging automation, cold-chain infrastructure, and near-shoring initiatives are further supporting expansion across global pharmaceutical supply chains.
Pharmaceutical Contract Packaging Market Key Growth Factors
Rising Serialization Requirements and Anti-Counterfeit Regulations
Stringent pharmaceutical traceability regulations across major healthcare markets are significantly increasing the adoption of contract packaging services. Governments worldwide continue to enforce serialization and tamper-evident packaging requirements to combat counterfeit medicines and improve supply chain transparency. Contract packaging organizations equipped with advanced serialization infrastructure, aggregation software, and automated inspection systems are becoming preferred partners for pharmaceutical manufacturers seeking regulatory compliance while minimizing capital investment.
Growing Demand for Biologics and Specialty Drug Packaging
The rapid expansion of biologics, biosimilars, injectable therapies, and specialty pharmaceuticals is creating substantial demand for highly specialized packaging solutions. Pre-filled syringes, cartridges, sterile packaging formats, and temperature-controlled packaging systems are witnessing strong adoption as pharmaceutical companies increasingly focus on self-administered therapies and personalized medicines. Contract packaging providers continue investing in aseptic packaging capabilities and advanced cleanroom infrastructure to meet evolving pharmaceutical requirements.
Increasing Preference for Integrated CDMO and Contract Packaging Services
Pharmaceutical companies are increasingly partnering with contract development and manufacturing organizations (CDMOs) that offer integrated manufacturing, packaging, labeling, serialization, and logistics services under a single quality framework. Outsourcing comprehensive packaging operations enables manufacturers to reduce operational complexity, shorten commercialization timelines, improve supply chain flexibility, and optimize production costs. AI-powered production monitoring, predictive maintenance, and automated line changeovers are further improving packaging efficiency and reducing validation time.
Ashish Gautam, Senior Research Manager, Mordor Intelligence, says, “As pharmaceutical companies continue to optimize supply chains and accelerate commercialization of biologics and specialty medicines, dependable market intelligence requires transparent sourcing, rigorous validation, and balanced analysis. Mordor Intelligence applies a structured research methodology to help decision-makers evaluate regulatory developments, outsourcing trends, competitive dynamics, and long-term opportunities across the global pharmaceutical contract packaging market.”
Pharmaceutical Contract Packaging Market Recent Industry Developments
April 27, 2026: PCI Pharma Services announced infrastructure investments exceeding USD 1 billion to expand its U.S. sterile fill-finish, drug-device combination assembly, and commercial packaging capabilities, including new high-speed isolator filling lines for pre-filled syringes, cartridges, vials, and advanced packaging operations.
May 2026: Alcami Corporation completed its acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and the Netherlands. The acquisition expands Alcami’s end-to-end CDMO capabilities across North America and Europe, adding more than 1 million square feet of operational space and strengthening its commercial pharmaceutical packaging, labeling, and supply chain services for pharmaceutical and biotechnology customers.
Pharmaceutical Contract Packaging Market Segmentation Insights
By Service Type
Primary
Bottles
Vials and Ampoules
Blister Packs
Secondary
Cartons
Labels and Inserts
Tertiary
By Packaging Format
Bottles
Plastic Bottles
Glass Bottles
Vials and Ampoules
Blister Packs
Sachets and Stick Packs
Pre-filled Syringes and Cartridges
By Drug Formulation
Solid Dosage
Tablets
Capsules
Oral Liquids
Injectable
Small-volume Parenterals
Large-volume Parenterals
By End User
Big Pharma (Revenue > USD 10 Billion)
Generics and Biosimilar Companies
Emerging Biotech and Start-ups
CRO and CDMO Partners
Other End Users
By Geography
North America: United States, Canada, Mexico
South America: Brazil, Argentina, Rest of South America
Europe: Germany, United Kingdom, France, Italy, Spain, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia & New Zealand, Rest of Asia-Pacific
Middle East: Saudi Arabia, United Arab Emirates, Turkey, Rest of Middle East
Africa: South Africa, Egypt, Nigeria, Rest of Africa
Pharmaceutical Contract Packaging Market Regional Insights
North America continues to lead the pharmaceutical contract packaging market, supported by a well-established pharmaceutical manufacturing ecosystem, stringent regulatory standards, and widespread adoption of serialization technologies. Increasing investments in biologics production, integrated CDMO services, and near-shoring strategies are driving demand for advanced contract packaging solutions across the United States and Canada.
Europe is witnessing steady market growth as pharmaceutical companies invest in sustainable packaging, regulatory compliance, and digital packaging technologies. The region is also experiencing increased adoption of automated packaging lines, recyclable materials, and cold-chain infrastructure to support specialty drugs and biologics.
Asia-Pacific is expected to register the fastest growth during the forecast period, driven by expanding pharmaceutical manufacturing capacity, growing contract development and manufacturing organizations (CDMOs), rising biosimilar production, and increasing healthcare investments. Countries such as India, China, South Korea, and Singapore continue to attract global pharmaceutical outsourcing due to cost competitiveness and expanding manufacturing capabilities.
The Pharmaceutical Contract Packaging Market Report Is Also Available in the Following Languages
Pharmaceutical Contract Packaging Market Competitive Landscape
The pharmaceutical contract packaging market is moderately concentrated, with companies competing through integrated CDMO services, serialization technologies, sterile packaging, and automated solutions. Leading players are expanding their manufacturing capabilities, investing in AI-driven automation and sustainable packaging, and strengthening end-to-end packaging services to meet growing demand for biologics, injectables, and specialty pharmaceuticals.
Pharmaceutical Contract Packaging Market Key Companies
PCI Pharma Services
Catalent Inc.
Sharp Packaging Services
Almac Group
Wasdell Group
Explore more insights on pharmaceutical contract packaging competitive landscape: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-packaging-market/companies?utm_source=einpr
Explore More Industry Research by Mordor Intelligence
Contract (Co-Packing) Services in Packaging Market Size
The Contract (Co-Packing) Services in Packaging Market is projected to grow from USD 20.61 billion in 2026 to USD 31.42 billion by 2031, registering a CAGR of 8.79% during the forecast period. Market growth is driven by increasing outsourcing of packaging operations, rising demand for automated and flexible packaging solutions, and growing adoption of sustainable packaging across consumer goods, healthcare, and industrial sectors.
Pharma and Medical Device Sterile Packaging Services Market Share
The Pharma and Medical Device Sterile Packaging Services Market is expected to reach USD 14.51 billion by 2030, expanding at a CAGR of 9.35% during the forecast period. Growth is supported by increasing demand for sterile packaging of biologics, injectable therapies, and medical devices, along with stringent regulatory requirements and rising investments in advanced sterile packaging technologies.
US Pharmaceutical CMO Market Growth
The United States Pharmaceutical CMO Market is projected to grow from USD 59.2 billion in 2026 to USD 77.56 billion by 2031, registering a CAGR of 5.55% during the forecast period. Market growth is driven by increasing outsourcing of pharmaceutical manufacturing, expanding biologics production, growing demand for integrated CDMO services, and continued investments in advanced drug development and commercialization capabilities.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For media inquiries or further information, please contact:
media@mordorintelligence.com
Mordor Intelligence Private Limited
https://www.mordorintelligence.com/
Jignesh Thakkar
Mordor Intelligence Private Limited
+1 617-765-2493
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
X
Other
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
